ACG St. Louis Corporate Peer Group Meeting (By Invitation Only)

Robert Wetzel is Vice President of Corporate Development at Enterprise Holdings, where he leads the Company’s Corporate Development activities, including mergers & acquisitions and corporate venture capital investments.  Bob also has strategic planning and partnership roles and responsibilities at Enterprise Holdings.  Prior to working at Enterprise, through his advisory company, Bob advised managers and owners of private companies and private equity/venture capital groups, on projects including M&A, temporary Senior Management, international, corporate development, corporate finance, regulatory, due diligence and strategic planning projects.  Mr. Wetzel founded Augury Capital in 2007, an emerging technologies venture capital fund.  Mr. Wetzel was a Senior Executive at Sigma-Aldrich Corporation, a leading life science company, for over seven years where he was the Managing Director of Asia and the Operations Manager for Europe.  In a Corporate Development Director role at Solutia, Robert was the Founder and Executor of Solutia’s Pharmaceutical Services division where he created Solutia's world-class pharmaceutical services division in Europe and directed their rapid international growth.  Robert was the CEO of US Spine, a Medical Device Company; President of Process Technologies & Packaging, a contract OTC Pharma and Cosmetics Development and Manufacturing Company; CEO of allvivo, a biotechnology company; and COO of Legacy Pharmaceutical Packaging.  Additionally, he was a LBO banker at the Bank of New York.  Robert was a founder, board member, advisor, or owner of numerous other emerging technology companies.

Mr. Wetzel is fluent in English and highly proficient in German.  Bob received a B.A. from Vanderbilt University, a M.B.A. from Carnegie-Mellon University Tepper School of Business, and a Biotechnology for Business certification from Duke University.